Table 2.

Demographic data for participants.

Treatment	Vagitocin 400 IU n = 24	Vagitocin 100 IU n = 24	Placebo n = 16
Age	61.1 ± 5.3	62.0 ± 5.7	63.2 ± 5.8
BMI	23.6 ± 3.2	23.1 ± 2.4	24.2 ± 2.6
Hysterectomy	n = 5 (20.8%)	n = 3 (12.5%)	n = 2 (12.5%)

BMI: body mass index.

Note. The table shows age (years), BMI (kg/m²), and the number of hysterectomies (yes) in the groups of women receiving vagitocin 400 IU, 100 IU and placebo.